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Summary.-Serum concentrations of oestradiol-17/ were measured by radio-
immunoassay during 40 menstrual cycles from 38 normal premenopausal women.
Repeated samples were studied from 25 normal postmenopausal women. The
method was highly specific and extremely sensitive. In premenopausal women the
pattern of serum oestradiol-17/ was remarkably constant but the concentrations
varied with age. Women in the fourth decade of life had significantly higher con-
centrations of oestradiol-17/ than either younger or older women. In postmeno-
pausal women the concentration of oestradiol-17f was consistently very low.
IT seems clear from clinical (Schin-
zinger, 1889; Beatson, 1896), experimental
(Loeb, 1919; Huggins, Briziarelli and
Sutton, 1959) and biochemical evidence
(Brown, 1958; Marmorston et al., 1965;
Persson and Risholm, 1964; Nissen-Meyer
and Sanner, 1963) that there is a relation-
ship between ovarian function and cancer
of the breast. Unfortunately it has not
been possible to define this relationship
in terms of hormonal activity because
simple methods for the measurement
of ovarian hormones in blood have not
been available.
It is now possible by means of radio-
immunoassay to measure simply and
accurately the concentration ofoestradiol-
17,8 in serum (Abraham, 1969; Cameron
and Jones, 1972) but the normal range has
not yet been defined. Previous studies
indicate that the concentrations are low
during thefollicular phaseofthe menstrual
cycle, that there is a well defined peak
at about the time of ovulation and a
second rise to a fairly high plateau during
the luteal phase. These variations, to-
gether with variability in the length of
the menstrual cycle, have made the
definition of a normal range extremely
difficult. Studies of individual samples
contribute little; it is necessary to examine
daily samples taken throughout the men-
strual cycle. In this study a group of
normal premenopausal women was studied
daily in an attempt to define the normal
range and relate it to the age of the
subjects. A further group of postmeno-
pausal and menopausal women was studied
repeatedly in a similar way. The object
of the study was to provide a normal
baseline with which to compare patients
with benign and malignant breast disease.
MATERIALS AND METHODS
Samples of blood were taken daily or
as often as possible during at least one
menstrual cycle from 38 normal premeno-
pausal women. Multiple samples were also
obtained from 25 normal postmenopausal
and 3 menopausal women (within one year
of cessation of periods). None had a
history of breast disease or gynaecological
abnormality and none was taking any form
of hormonal preparation. The ages of the
38 premenopausal subjects ranged from 21
to 53 years (mean 34 8). Of these, 14 were
aged 20-29 years, 13 were 30-39 years,
10 were 40-49 years and one was 53 years
of age. The ages of the normal postmeno-
pausal subjects ranged from 47 to 64 years
(mean 56).SERUM OESTRADIOL-17fl IN NORMAL WOMEN
Diethyl ether (Pronalys peroxide-free)
was obtained from May and Baker, and a
freshly opened 500 ml bottle was used for
each assay. Ethanol (analytical grade) was
supplied by James Burroughs Ltd, London;
benzene and methanol (scintillation grades)
by Koch-Light and 1,4 dioxan (Analar) by
BDH. Dextran T-70 was supplied by Phar-
macia; gelatin by the Sterling Gelatine Co.
Ltd, and Norit-A-charcoal by Sigma Ltd.
Oestradiol-17f(E2) and scintillation grade
1,4-bis-2-(4-methyl-5-phenyloxazolyl) ben-
zene (dimethyl POPOP) were purchased
from Koch-Light and the 2-5 diphenyloxazole
(PPO) from Fisons Scientific Apparatus Ltd,
Loughborough. (2,4,6,7-3H4) oestradiol-17/3
(100 Ci/mmol) was obtained from the Radio-
chemical Centre, Amersham, Bucks. The
antiserum, anti-E2 17/3-6-BSA (Dean, Exley
and Johnson, 1971) was a gift from Dr
E. H. D. Cameron, Tenovus Institute,
Cardiff. It was stored at -15°C and
diluted to a concentration of 1 in 30,000
for use in the assay. The assay was per-
formed in disposable glass tubes (12 x 75
mm). After use, other glassware was im-
mersed overnight in a chromic acid bath,
thoroughly rinsed with tap and deionized
water and oven dried.
Collection of blood samples.-Peripberal
venous blood (approximately 10 ml) was
collected daily between 9 a.m. and 12 noon.
The blood was allowed to clot, centrifuged
and the serum removed and stored at
-200C.
Radioimmunoassay of oestradiol-17f.-
Oestradiol-17,B was extracted from samples
of serum after addition of 15% v/v carbonate
buffer (pH 9.4) by shaking with ether. The
ether layer was removed with a Pasteur
pipette and evaporated to dryness at 40°C
under nitrogen. The assay was based on
that described by Cameron and Jones (1972).
The high specificity of the anti-E217fl-6-BSA
permitted precise determination of oestradiol
without preliminary chromatographic separa-
tion. The cross-reaction with oestrone and
oestriol was about 1% (Dean et al., 1971).
Ether residues were dissolved in 01 -I%
gelatin in 0-01 mol/l sodium phosphate
buffer/0*15 mol/l.NaCl (pH 7.4) (PBS) which
contained the required amount of (1,2,6,7-
3H4) oestradiol-17fl for the assay (ca. 20 pg).
The antiserum, diluted to a concentration
of 1 in 30,000 in 0-1% gelatin PBS, was then
added and the mixture incubated overnight
at 4°C. Free and bound fractions were
separated by means of dextran-charcoal
suspended in 0.1% gelatin PBS and the
radioactivity of an aliquot ofthe supernatant
fluid was counted by liquid scintillation
spectrometry (Fig. 1).
When sera from premenopausal women
were studied duplicate samples of 0-3 ml
were extracted with ether and the extracts
evaporated to dryness in the assay incuba-
tion tubes, where they were redissolved
directly in gelatin PBS. Each cycle was
assayed as a unit so that fluctuations would
represent intra- rather than interassay varia-
tion.
When larger samples were required for
postmenopausal sera (0.6-1-2 ml) 5 ml of
ether were used for the extraction; the
residues were redissolved in 800 ,ul
ethanol and aliquots of 500 ,ll were trans-
ferred to the assay tubes and evaporated to
dryness.
This procedure was also followed when
internal tracer standard (2000 d/min triti-
ated oestradiol) was added to the plasma
to test efficiency of extraction. Aliquots
of 100 ,ul were transferred to vials and
evaporated to dryness in the presence of a
drop of solution of " cold " E217/3 in ethanol
(10 dul/ml) for determination of the radio-
activity in toluene scintillator. E217,p
standards (5-150 pg) were prepared in
ethanol solution. A constant volume (100
pl) of appropriate solution was delivered
into each of the standard tubes, and 100 ,ul
ethanol to all other tubes in the assay.
Evaporation under nitrogen took place at
40°C. The appropriate volume of ether
was added to all standard and control tubes
and evaporated to dryness to compensate
for any effect of the solvent on the standard
curve.
Meaisurement of radioactivity.-An aliquot
of 500 ,ul of the supernatant fluid from each
sample was added to a vial which contained
10 ml of Bray's scintillator (Bray, 1960) and
counted in a Nuclear Chicago Isocap/300
liquid scintillation system using Programme
lB. Counting efficiency was approximately
25%. In order to check the efficiency of
extraction, 100 ,ul of ethanolic extract plus
added " cold " E217/3 were evaporated to
dryness in a vial and the content of radio-
activity determined after addition of 5 ml
toluene scintillator which contained 033%
PPO and 0.01% dimethyl POPOP. Effi-
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Ether extraction
Centrifugation
Evaporation
Taken up in 200 14
0 1% gelatin PBS
Equilibration of antiserum with extracts
and series of standards
(a) Add 3H-E2 (24,000 d/min) 0*1 ml in 0 1% gelatin PBS
(b) Addl antibody 0-1 ml in 0-1% gelatin PBS
Mix and incubate at 4°C overnight
Separation of bound/unbound at 4°C'
(a) Add 0 1 ml 0 5% gelatin in PBS
(b) Addt I-0 ml dextran charcoal suispensiion
(e) Mix, centi-ifiige 16 mnin at 2000 rev/minn
|R,esidue |
|Suipernatant boun(l
Liqui(d scintillation counting
0 5 ml suipernatant into 10 ml Bray's Scintillator|
FIG. 1. Flow diagram of method of radioimmunoassay for oestradiol-17/?.
ciency of counting in this medium was
approximately 45%.
Criteria of the assay.-All assays were
performed in duplicate and each assay
included a standard curve.
Recovery: The mean recovery oftritiated
internal standard from 488 samples of serum
was 97'6 ± 0-3% (s.e. mean).
Specificity: The only major cross-reacting
steroid was 6-keto-17,B-oestradiol which does
not occur in human biological fluids. Cross
reaction to oestrone was 0.97% and to
oestriol 1.2%.
Sensitivity: For each assay, 6 " water
blanks " were taken through the whole
procedure. The mean blank was 1-2 ± 0-2
(s.e. mean)pg for 68 assays; this indicates a
sensitivity in terms of 95% confidence
limits of a -reagent blank of4-4 pg.
Accuracy: The accuracy of the method
was estimated by recovery of added oestra-
diol. The mean recovery was 84-4 + 2.5%
(s.e. mean) at the 20 pg/ml level and
83.3±2.2% at the 50 pg/ml level (n = 68).
Precision: The interassay precision was
clculated from 18 separate duplicate deter-
minations of quality control samples pre-
pared from pooled plasma. This gave a
mean value of 61-0 + 3.3 (s.e. mean)pg/ml.
(coefficient of variation 9-8%). Duplicate
values from 4 complete menstrual cycles
taken at random showed a standard error
of reproducibility of 11 2 and a coefficient
of variation of 8-9%.
Mea8urement of luteinizing hormone.-In
6 of the premenopausal women serum
luteinizing hormone was also estimated by
a standard double antibody procedure. The
MRC HPLH Preparation 68/40 was used as
the reference material.SERUM OESTRADIOL-17/J IN NORMAL WOMEN
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FIG. 3. Relation between mean concentrations of luteinizing hormone and oestradiol-17/3 in 6 normal
premenopausal women. The day of the oestradiol-17fl peak is characterized as zero on the hori-
zontal scale; preceding days are prefixed by a (-) sign and subseqtuent days are positive.
RESULTS cycles varied greatly (17-39 days) so that
Premenopaasal women a reference point other than the first
(a) The normal range.-A constant day of the cycle was needed for com-
pattern was found in 36 of the 40 cycles parative purposes. Others have used the
studied (Fig. 2). The lengths of the time of the mid-cycle peak of luteinizing
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FIG. 4.-Mean concentrations of oestradiol-17fl in 30 normal premenopausal women. The hatched
area indicates one standard error of the mean.
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FIG. 5.-Mean concentrations of oestradiol-17fl in normal premenopausal women in third, fourth ana
fifth decades of life. Paired statistical comparisons of the luteal phases: 3rd decade vs. 4th decade
t=4 24P<0 01; 3rd decade vs. 5th decade t=7 05P<0 001; 4th decade vs. 5th decade t=9-98
P <0*001.
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hormone as a reference point. In the 6
subjects in whom luteinizing hormone was
measured, this peak was consistently 24
hours after the ovulatory oestradiol peak
(Fig. 3). Consequently the latter was
chosen as the reference point and referred
to as Day 0. Preceding days were
referred to as negative numbers and the
days following as positive numbers.
When orientated in this way, the
mean concentrations of oestradiol-17,/ in
30 completely studied cycles were as
follows: (1) follicular phase (Days 11
to 4) 35.3 ± 4.39 (s.e. mean)pg/ml; (2)
ovulatory peak (Day 0) 192-9 AE 12-7
(s.e. mean)pg/ml; (3) luteal phase (Days
+4 to + 12) 67-3 ± 1-47 (s.e. mean)pg/ml.
(Fig. 4). Six incomplete cycles in which
Day 0 could not be exactly defined were
omitted from the statistical analyses.
(b) Effect of age. During the luteal
phase there were marked differences in
concentration ofoestradiol between women
in the third, fourth and fifth decades of
life (Fig. 5).
When examined by the method of
paired statistical comparisons the con-
centrations in women in the fourth
decade were significantly higher than
those of women in the third (P < 0.01).
These in turn were significantly higher
than those of women in the fifth decade
(P <-0.001). Themagnitude ofthe ovula-
tory peak was greater during the fourth
decade than in the other two decades
(Table). When the concentrations in the
fourth and third decades were compared
the difference was significant (P < 0 01).
TABLE. Comparison of Mean Ovulatory
Peaks for Women in Different Age
Groups
Age
(years)
20-29
30-39
40-49
No. of
cycles
12
10
8
AMean values of ovulatory peak
(oestradiol- 17fl pg/ml
s.e. mean)
1684-I4- 11 8
238 6-6-20-0
172-6+31-7
Statistics: 4th cleca(le vs. 3rd deca(c t
P < 001; 4th decade vs. 5th decade t
P < 0-1.
(c) Abnormal cycles.-Four subjects
had a pattern which differed from the
others. In 2 there were high peaks
(240 and 220 pg/ml) on the fourth and
fifth days respectively; in a further
cycle from one of these the abnormality
was no longer apparent. The other 2
subjects, aged 47 and 53 years, had no
ovulatory peak but plateaux were ap-
parent later in the cycle.
Postmenopausal women
In postmenopausal women the con-
centrations were consistently low in each
of the 25 subjects (mean 5.7 i 0 33)
(s.e. mean)pg/ml.
Menopausal women
Bizarre results were found in each
of the 3 women studied at the time of the
menopause (Fig. 6).
DISCUSSION
The advantages of the method used
in this study were its specificity and the
high degree of sensitivity. Only small
quantities of serum were required from
both premenopausal (0 3 ml) and post-
menopausal women (0 6-1*2 ml).
The considerable variation in the
length of the menstrual cycle (17-39
days) and in particular the variation in
timing of the ovulatory peak (8th-18th
day) demanded that, for comparative
purposes, cycles be synchronized around
a reference point other than the first
day of menstruation. Most authors (Ab-
raham et al., 1972; Mishell et al., 1971)
have related their data to the sharply
defined mid-cycle peak of luteinizing
hormone. Our results and those of other
workers (Mishell et al., 1971; Korenman
and Sherman, 1973) indicate that the
peak of luteinizing hormone occurs con-
sistently 24-36 hours after the ovulatory
peak of oestradiol-17/3. The luteinizing
hormone peak is transient and may be
easily missed without comprehensive serial
assays (Shaaban and Klopper, 1973), so
it seemed simpler to use the ovulatory
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FiGo. 6.-Mean concentrations of oestradiol-177fl in 3 menopausal women.
peak of oestradiol itself as the reference
point. The results for the 30 complete
cycles studied in this way were remarkably
consistent and the standard error through-
out the range was small.
It is difficult to explain why women
in the fourth decade of life had higher
concentrations of oestradiol than younger
and older women. Women in their late
twenties and thirties are known to have
a more stabilized menstrual pattern,
whereas younger and older women have a
tendency to be more erratic, especially
with regard to the length of their cycles
(Treloar et al., 1967).
In 2 women a peak of oestradiol
occurred very early in the cycle while
menstruation was still taking place and
in one at least it was related to a peak
of luteinizing hormone. It is suggested
that the peak of oestradiol normally
acts as the trigger for ovulation (Vande
Weile et al., 1970) but it is difficult to
believe that ovulation was taking place
at this very early stage of the cycle.
Estimations were repeated in one of these
subjects throughout a further cycle,
which followed a normal pattern. The
pattern in a further 2 subjects also
differed from the normal. The ovulatory
peak of oestradiol did not occur but a
plateau in the latter part of the cycle
was present. Both subjects were ap-
proaching the age of the menopause and
it may be that their cycles were anovu-
latory.
As expected, the concentrations of
oestradiol-17,8 in postmenopausal women
were extremely low. The source of these
small amounts of oestrogen may be from
endogenous conversion of androgens and
not from ovarian secretion (Barlow,
Emerson and Saxena, 1969; Longcope,
1971).SERUM OESTRADIOL-17/3 IN NORMAL WOMEN 469
The results from 2 of the 3 women
whose periods had recently ceased were
high, and this suggests that there may
be considerable ovarian function for at
least one year after cessation of menstrua-
tion. In one of these women the con-
centration had fallen dramatically when
she was studied a second time one year
after her periods had ceased.
With these few exceptions, the pattern
throughout the study was remarkably
consistent and the data seemed to provide
a normal baseline with which to compare
patients with endocrine abnormalities and
in particular, for our purposes, those
with diseases of the breast. A study in
which the serum concentrations of oestra-
diol-17,8 in premenopausal women with
fibroadenosis and cystic disease of the
breast and in women with cancer of the
breast were compared with the normal
pattern, has just been completed. The
results will be reported.
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